190 related articles for article (PubMed ID: 25808168)
1. Expression of the IL-11 Gene in Metastatic Cells Is Supported by Runx2-Smad and Runx2-cJun Complexes Induced by TGFβ1.
Zhang X; Wu H; Dobson JR; Browne G; Hong D; Akech J; Languino LR; Stein GS; Lian JB
J Cell Biochem; 2015 Sep; 116(9):2098-108. PubMed ID: 25808168
[TBL] [Abstract][Full Text] [Related]
2. Runx2 association with progression of prostate cancer in patients: mechanisms mediating bone osteolysis and osteoblastic metastatic lesions.
Akech J; Wixted JJ; Bedard K; van der Deen M; Hussain S; Guise TA; van Wijnen AJ; Stein JL; Languino LR; Altieri DC; Pratap J; Keller E; Stein GS; Lian JB
Oncogene; 2010 Feb; 29(6):811-21. PubMed ID: 19915614
[TBL] [Abstract][Full Text] [Related]
3. Integrin αvβ3 and CD44 pathways in metastatic prostate cancer cells support osteoclastogenesis via a Runx2/Smad 5/receptor activator of NF-κB ligand signaling axis.
Gupta A; Cao W; Chellaiah MA
Mol Cancer; 2012 Sep; 11():66. PubMed ID: 22966907
[TBL] [Abstract][Full Text] [Related]
4. Runx2-Smad signaling impacts the progression of tumor-induced bone disease.
Zhang X; Akech J; Browne G; Russell S; Wixted JJ; Stein JL; Stein GS; Lian JB
Int J Cancer; 2015 Mar; 136(6):1321-32. PubMed ID: 25053011
[TBL] [Abstract][Full Text] [Related]
5. Runx2 transcriptional activation of Indian Hedgehog and a downstream bone metastatic pathway in breast cancer cells.
Pratap J; Wixted JJ; Gaur T; Zaidi SK; Dobson J; Gokul KD; Hussain S; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Cancer Res; 2008 Oct; 68(19):7795-802. PubMed ID: 18829534
[TBL] [Abstract][Full Text] [Related]
6. Metastatic breast cancer cells inhibit osteoblast differentiation through the Runx2/CBFβ-dependent expression of the Wnt antagonist, sclerostin.
Mendoza-Villanueva D; Zeef L; Shore P
Breast Cancer Res; 2011 Oct; 13(5):R106. PubMed ID: 22032690
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor and TGFbeta1/Smad signaling are mutually inhibitory in prostate cancer.
van der Poel HG
Eur Urol; 2005 Dec; 48(6):1051-8. PubMed ID: 16257107
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptors β1 and β2 have opposing roles in regulating proliferation and bone metastasis genes in the prostate cancer cell line PC3.
Dey P; Jonsson P; Hartman J; Williams C; Ström A; Gustafsson JÅ
Mol Endocrinol; 2012 Dec; 26(12):1991-2003. PubMed ID: 23028063
[TBL] [Abstract][Full Text] [Related]
9. Runx2 transcriptome of prostate cancer cells: insights into invasiveness and bone metastasis.
Baniwal SK; Khalid O; Gabet Y; Shah RR; Purcell DJ; Mav D; Kohn-Gabet AE; Shi Y; Coetzee GA; Frenkel B
Mol Cancer; 2010 Sep; 9():258. PubMed ID: 20863401
[TBL] [Abstract][Full Text] [Related]
10. Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo.
Nesbitt H; Browne G; O'Donovan KM; Byrne NM; Worthington J; McKeown SR; McKenna DJ
J Cell Physiol; 2016 Feb; 231(2):473-82. PubMed ID: 26189652
[TBL] [Abstract][Full Text] [Related]
11. Smad3 interacts with JunB and Cbfa1/Runx2 for transforming growth factor-beta1-stimulated collagenase-3 expression in human breast cancer cells.
Selvamurugan N; Kwok S; Partridge NC
J Biol Chem; 2004 Jun; 279(26):27764-73. PubMed ID: 15084595
[TBL] [Abstract][Full Text] [Related]
12. FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion.
Zhang H; Pan Y; Zheng L; Choe C; Lindgren B; Jensen ED; Westendorf JJ; Cheng L; Huang H
Cancer Res; 2011 May; 71(9):3257-67. PubMed ID: 21505104
[TBL] [Abstract][Full Text] [Related]
13. Runx2 induces bone osteolysis by transcriptional suppression of TSSC1.
Wang DC; Wang HF; Yuan ZN
Biochem Biophys Res Commun; 2013 Sep; 438(4):635-9. PubMed ID: 23933319
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2.
Colden M; Dar AA; Saini S; Dahiya PV; Shahryari V; Yamamura S; Tanaka Y; Stein G; Dahiya R; Majid S
Cell Death Dis; 2017 Jan; 8(1):e2572. PubMed ID: 28125091
[TBL] [Abstract][Full Text] [Related]
15. c-Jun Contributes to Transcriptional Control of GNA12 Expression in Prostate Cancer Cells.
Udayappan UK; Casey PJ
Molecules; 2017 Apr; 22(4):. PubMed ID: 28394299
[No Abstract] [Full Text] [Related]
16. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein.
Lee KS; Hong SH; Bae SC
Oncogene; 2002 Oct; 21(47):7156-63. PubMed ID: 12370805
[TBL] [Abstract][Full Text] [Related]
17. The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion.
Pratap J; Javed A; Languino LR; van Wijnen AJ; Stein JL; Stein GS; Lian JB
Mol Cell Biol; 2005 Oct; 25(19):8581-91. PubMed ID: 16166639
[TBL] [Abstract][Full Text] [Related]
18. Structural coupling of Smad and Runx2 for execution of the BMP2 osteogenic signal.
Javed A; Bae JS; Afzal F; Gutierrez S; Pratap J; Zaidi SK; Lou Y; van Wijnen AJ; Stein JL; Stein GS; Lian JB
J Biol Chem; 2008 Mar; 283(13):8412-22. PubMed ID: 18204048
[TBL] [Abstract][Full Text] [Related]
19. Role of Runx2 phosphorylation in prostate cancer and association with metastatic disease.
Ge C; Zhao G; Li Y; Li H; Zhao X; Pannone G; Bufo P; Santoro A; Sanguedolce F; Tortorella S; Mattoni M; Papagerakis S; Keller ET; Franceschi RT
Oncogene; 2016 Jan; 35(3):366-76. PubMed ID: 25867060
[TBL] [Abstract][Full Text] [Related]
20. Characterization of CD44 intracellular domain interaction with RUNX2 in PC3 human prostate cancer cells.
Senbanjo LT; AlJohani H; Majumdar S; Chellaiah MA
Cell Commun Signal; 2019 Jul; 17(1):80. PubMed ID: 31331331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]